EDSERIE MUNOZ: Open Payments
NPI 1437704947 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 22 payments from 10 companies in 2025. Trend: 2023 $246 · 2024 $385 · 2025 $811
Food & beverage: $726Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $182 |
| Braintree Laboratories, Inc. | 2 | $163 |
| Lucid Diagnostics Inc. | 2 | $140 |
| GENZYME CORPORATION | 1 | $120 |
| Janssen Biotech, Inc. | 1 | $85 |
| Madrigal Pharmaceuticals | 1 | $40 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Teleflex LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
Products named: SUTAB, LINZESS, DUPIXENT, TREMFYA, REZDIFFRA, KEYTRUDA, CREON, UROLIFT.
Industry payments across FL — which companies pay providers there.
